The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a recall for a batch of Cyclizine Lactate 50mg/ml Solution for Injection, a medication commonly used to prevent and treat nausea and vomiting, including sickness after surgery and other medical treatments. The recall is due to concerns over Good Manufacturing Practice (GMP) deficiencies at the manufacturing site.
Healthcare Professionals Advised to Stop Supply Immediately
Healthcare professionals have been instructed to stop supplying the affected batch immediately, quarantine any remaining stock, and return it to their supplier as a precautionary measure. The MHRA has classified this as a Class 3 Medicines Recall, indicating that the action is being taken out of an abundance of caution.
Patients Should Continue Taking Their Medication
The MHRA has emphasized that patients should not stop taking their medicine if it has been prescribed to them. No further action is required by patients, as the recall is being undertaken at a pharmacy and wholesaler level. Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Previous Recall for Blood Pressure Medication
This recall follows a recent incident where a batch of ramipril 2.5mg capsules, a commonly prescribed medication for high blood pressure, was recalled after a packaging mistake led to some boxes containing a stronger dose than intended. The MHRA advised anyone taking Crescent Pharma's ramipril capsules to carefully check their packaging.
